2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,244 | 74,958 | 71,032 | 130,414 | N/A |
| Marketable Securities | 103,510 | 142,031 | 195,238 | 134,643 | N/A |
| Receivables | 7,781 | 13,411 | 20,960 | 16,995 | 10,691 |
| TOTAL | $187,256 | $237,765 | $300,882 | $291,564 | $25,104 |
| Non-Current Assets | |||||
| PPE Net | 33,759 | 58,150 | 55,735 | 34,913 | 144,025 |
| Investments And Advances | 8,867 | 4,816 | 1,414 | 97,124 | 0 |
| Intangibles | 5,885 | 6,594 | 19,358 | 21,948 | 18,772 |
| Other Non-Current Assets | 243,743 | 258,101 | 279,276 | 314,126 | 124,719 |
| TOTAL | $292,254 | $327,661 | $355,783 | $468,111 | $287,516 |
| Total Assets | $479,510 | $565,426 | $656,665 | $759,675 | $312,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,055 | 6,028 | 7,208 | 6,024 | 7,152 |
| Accrued Expenses | 22,672 | 25,688 | 54,678 | 55,410 | 43,347 |
| Other current liabilities | N/A | N/A | 3,744 | 22,185 | 9,236 |
| TOTAL | $40,092 | $59,779 | $79,794 | $98,388 | $75,868 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 15,403 | 3,000 | 5,000 | 820 |
| Other Non-Current Liabilities | 228,612 | 246,429 | 261,405 | 275,703 | 136,361 |
| TOTAL | $228,612 | $250,347 | $266,405 | $301,465 | $162,123 |
| Total Liabilities | $268,704 | $310,126 | $346,199 | $399,853 | $237,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,338 | 51,311 | 50,190 | 37,616 | N/A |
| Common Shares | 5 | 5 | 4 | 2 | N/A |
| Retained earnings | -568,464 | -511,217 | -293,647 | -39,494 | N/A |
| Other shareholders' equity | 89 | -204 | -2,877 | -712 | 74,629 |
| TOTAL | $210,806 | $255,300 | $310,466 | $359,822 | $74,629 |
| Total Liabilities And Equity | $479,510 | $565,426 | $656,665 | $759,675 | $312,620 |